Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(0.04%) $80.09
Gas
(1.75%) $2.67
Gold
(0.97%) $2 440.80
Silver
(3.79%) $32.45
Platinum
(0.85%) $1 099.30
USD/EUR
(-0.08%) $0.919
USD/NOK
(-0.12%) $10.66
USD/GBP
(-0.02%) $0.787
USD/RUB
(0.08%) $91.05

Realtime updates for Solasia Pharma K.K. [4597.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Last Updated20 May 2024 @ 00:37
25% discount on Stockinvest.us - Use code: Podcast

3.70% ¥ 27.00

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 00:37):

Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting...

Stats
Today's Volume 5.19M
Average Volume 3.09M
Market Cap 4.92B
EPS ¥0 ( 2024-05-15 )
Next earnings date ( ¥0 ) 2024-08-07
Last Dividend ¥0 ( N/A )
Next Dividend ¥0 ( N/A )
P/E -4.08
ATR14 ¥0.380 (1.36%)

Volume Correlation

Long: 0.06 (neutral)
Short: 0.60 (weak)
Signal:(51.556) Neutral

Solasia Pharma K.K. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Solasia Pharma K.K. Correlation - Currency/Commodity

The country flag -0.62
( weak negative )
The country flag -0.44
( neutral )
The country flag -0.50
( neutral )
The country flag -0.09
( neutral )
The country flag 0.10
( neutral )
The country flag 0.55
( weak )

Solasia Pharma K.K. Financials

Annual 2023
Revenue: ¥617.00M
Gross Profit: ¥-163.00M (-26.42 %)
EPS: ¥-6.61
FY 2023
Revenue: ¥617.00M
Gross Profit: ¥-163.00M (-26.42 %)
EPS: ¥-6.61
FY 2022
Revenue: ¥1.09B
Gross Profit: ¥662.00M (60.62 %)
EPS: ¥-16.76
FY 2021
Revenue: ¥559.00M
Gross Profit: ¥374.00M (66.91 %)
EPS: ¥-19.04

Financial Reports:

No articles found.

Solasia Pharma K.K. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Solasia Pharma K.K.

Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 a chemotherapy induced peripheral neuropathy which is in pre-clinical stage. In addition, the company is developing SP-05 (Arfolitixorin) that is in phase III clinical study for the enhancement of antitumor efficacy of fluorouracil, including the treatment for pancreatic cancer, breast cancer, stomach cancer, and head and neck cancers. Solasia Pharma K.K. was founded in 2006 and is based in Tokyo, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators